(Q48010180)

7 February 2018

title

Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias (English)

1 reference

7 February 2018

Creutzfeldt-Jakob disease

main subject

cerebrospinal fluid

0 references

dementia

0 references

1 reference

5

1 reference

7 February 2018

Eugeen Vanmechelen

7

object named as

Vanmechelen E

1 reference

7 February 2018

Hans Förstl

8

object named as

Förstl H

1 reference

7 February 2018

Matthias Riemenschneider

1

object named as

Riemenschneider M

1 reference

7 February 2018

author name string

Wagenpfeil S

2

1 reference

7 February 2018

Vanderstichele H

3

1 reference

7 February 2018

Otto M

4

1 reference

7 February 2018

Kretzschmar H

6

1 reference

7 February 2018

Kurz A

9

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 March 2003

1 reference

7 February 2018

published in

Molecular Psychiatry

1 reference

7 February 2018

volume

8

1 reference

7 February 2018

issue

3

1 reference

7 February 2018

page(s)

343-347

1 reference

7 February 2018

https://scigraph.springernature.com/pub.10.1038/sj.mp.4001220

exact match

0 references

cites work

The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001220

7 January 2021

Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001220

7 January 2021

CSF detection of the 14-3-3 protein in unselected patients with dementia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001220

7 January 2021

Mechanism of Alzheimer neurofibrillary degeneration and the formation of tangles.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001220

7 January 2021

Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt–Jakob disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001220

7 January 2021

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001220

7 January 2021

Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001220

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001220

7 January 2021

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001220

7 January 2021

Descriptive epidemiology of Creutzfeldt-Jakob disease in six European countries, 1993-1995. EU Collaborative Study Group for CJD.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001220

7 January 2021

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001220

7 January 2021

Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001220

7 January 2021

Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001220

7 January 2021

ELISA-quantitation of phosphorylated tau protein in the Alzheimer's disease brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001220

7 January 2021

Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001220

7 January 2021

Molecular classification of the dementias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001220

7 January 2021

Both total and phosphorylated tau are increased in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001220

7 January 2021

Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001220

7 January 2021

Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer's disease patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001220

7 January 2021

Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001220

7 January 2021

Identifiers

DOI

10.1038/SJ.MP.4001220

1 reference

7 February 2018

1 reference

7 February 2018